The most recent conceptualization of AD, as expressed by the A/T/N framework, defines the disease based on the presence or absence of three classes of biomarkers: amyloid pathology (A), tau pathology (T), and neurodegeneration (N) [10,11]. Here, MAPT is linked to Alzheimer disease.